Frankfurt am Main, Germany

Petra Loos

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Petra Loos - Innovator in Pharmaceutical Formulations

Introduction

Petra Loos is a prominent inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of insulin analogues and derivatives. With a total of five patents to her name, Petra has established herself as a key figure in her industry.

Latest Patents

Among her latest patents are "Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives," which disclose innovative methods for enhancing the stability of these critical medications. Another notable patent is for "Stabilized pharmaceutical formulations of insulin aspart," which also focuses on improving the formulation of insulin products for better efficacy and safety.

Career Highlights

Petra Loos is currently employed at Sanofi, a global healthcare leader. Her work at Sanofi has allowed her to collaborate with other experts in the field, further advancing the development of effective pharmaceutical solutions.

Collaborations

Throughout her career, Petra has worked alongside notable colleagues such as Oliver Bley and Bernd Bidlingmaier. Their combined expertise has contributed to the successful development of innovative pharmaceutical products.

Conclusion

Petra Loos is a distinguished inventor whose work in pharmaceutical formulations has had a significant impact on the industry. Her contributions continue to shape the future of insulin therapies and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…